P Starosta

Discipline

Economies et finances (4)

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Social sciences (6) Atrial fibrillation (6) Patients (5) Patients (5) recherche (4) programme (4) Research (4) Research (4) risque (3) Methods (3) Risk (3) Cerebrovascular disease (3) Methods (3) mortalité (2) analyse (2) danger (2) taux (2) Mortality (2) Treatment (2) Prevention (2) Death (2) Vitamin K (2) Ci (Chinese poetry) (2) Regression analysis (2) Mortality (2) Months (2) Impact (2) Death (2) Confidence (2) Utilization (2)

Documents écrit par P Starosta (6) | parle de P Starosta (0)

Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Wern Yew Ding et al. (1 mai 2022)
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry
Pitt‐kerby T et al. (19 mars 2022)
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
Marco Proietti et al. (déc. 2021)
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
Cyril Zakine et al. (1 juil. 2019)
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry
Giuseppe Boriani et al. (1 mai 2018)
The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists
Wern Yew Ding et al. (29 avr. 2015)